US Diagnostics
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
711 3rd Ave Rm 1502, New York, New York,...Phone Number
(866) 216-5308Website
www.usdiagnostics.netRevenue
$18.6 MillionIndustry
About US Diagnostics
US Diagnostics, Inc. specializes in providing high-quality diabetes management products, including blood glucose monitoring systems, insulin pen needles, and syringes. The company aims to serve individuals with diabetes by offering affordable and reliable solutions for blood glucose monitoring. They have established partnerships to enhance distribution and accessibility of their products. With a commitment to innovation, US Diagnostics continues to expand its product line to meet the needs of their clients.Explore more
US Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to US Diagnostics
Compare insights from companies similar to US Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
US Diagnostics Tech Stack
A closer look at the technologies used by US Diagnostics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding US Diagnostics
Sign Up For FreeTo access detailed company insights
US Diagnostics, Inc. specializes in providing high-quality diabetes management products, including blood glucose monitoring systems, insulin pen needles, and syringes. The company aims to serve individuals with diabetes by offering affordable and reliable solutions for blood glucose monitoring. They have established partnerships to enhance distribu... Read More
